AYUR.F Stock Overview
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Ayurcann Holdings Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.032 |
52 Week High | CA$0.12 |
52 Week Low | CA$0.0075 |
Beta | 1.77 |
11 Month Change | -20.75% |
3 Month Change | -32.55% |
1 Year Change | 107.24% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -81.47% |
Recent News & Updates
Recent updates
Shareholder Returns
AYUR.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -2.7% | 0.9% |
1Y | 107.2% | 21.5% | 32.4% |
Return vs Industry: AYUR.F exceeded the US Pharmaceuticals industry which returned 22.2% over the past year.
Return vs Market: AYUR.F exceeded the US Market which returned 32.1% over the past year.
Price Volatility
AYUR.F volatility | |
---|---|
AYUR.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: AYUR.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AYUR.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Igal Sudman | ayurcann.com |
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. It offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. The company sells product under the Fuego, H&S, XPLOR, JOINTS and BRAVO6 brands.
Ayurcann Holdings Corp. Fundamentals Summary
AYUR.F fundamental statistics | |
---|---|
Market cap | US$5.05m |
Earnings (TTM) | -US$3.30m |
Revenue (TTM) | US$17.24m |
0.3x
P/S Ratio-1.5x
P/E RatioIs AYUR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AYUR.F income statement (TTM) | |
---|---|
Revenue | CA$23.28m |
Cost of Revenue | CA$15.31m |
Gross Profit | CA$7.96m |
Other Expenses | CA$12.42m |
Earnings | -CA$4.46m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.023 |
Gross Margin | 34.21% |
Net Profit Margin | -19.17% |
Debt/Equity Ratio | 13.0% |
How did AYUR.F perform over the long term?
See historical performance and comparison